News

Filter

Current filters:

None

1 to 9 of 97892 results

Orexigen shares jump on Contrave trial interim data but FDA orders more cardio studies

Orexigen shares jump on Contrave trial interim data but FDA orders more cardio studies

04-03-2015

The US Food and Drug Administration has said it is “disappointed” by Orexigen Therapeutics’ decision…

ContraveMetabolicsNeurologicalOrexigen TherapeuticsPharmaceuticalRegulationUSA

FDA formally accepts Actelion's NDA for Uptravi

04-03-2015

Switzerland-based Actelion, Europe’s largest biotech company, says that the US Food and Drug Administration…

ActelionBiotechnologyRegulationRespiratory and PulmonaryselexipagUptraviUSA

Bavarian Nordic set to earn $975 million in Prostvac deal

Bavarian Nordic set to earn $975 million in Prostvac deal

04-03-2015

Danish biotech firm Bavarian Nordic has granted US pharma major Bristol-Myers Squibb an exclusive option…

Bavarian NordicBiotechnologyBristol-Myers SquibbLicensingOncologyProstvacVaccinesYervoy

First launch for Eisai’s Lenvima, in the USA

First launch for Eisai’s Lenvima, in the USA

03-03-2015

The US subsidiary of Japanese pharma major Eisai has now launched its in-house developed novel anticancer…

EisailenvatinibLenvimaMarkets & MarketingOncologyPharmaceuticalRare diseases

Mylan sales and revenue up while EpiPen becomes its first $1 billion-selling product

Mylan sales and revenue up while EpiPen becomes its first $1 billion-selling product

03-03-2015

US generic drugmaker Mylan has reported strong growth throughout the company for the fourth quarter and…

FinancialGenericsMylanPharmaceutical sciencesUSA

Lilly licenses pomaglumetad methionil to Denovo as potential schizophrenia therapy

Lilly licenses pomaglumetad methionil to Denovo as potential schizophrenia therapy

03-03-2015

US drug major Eli Lilly has licensed late-stage neuroscience drug pomaglumetad methionil (mGlu2/3 receptor…

Eli LillyLicensingNeurologicalPharmaceuticalpomaglumetad methionilUSA

Blueprint Medicines in up to $265 million deal with Alexion

03-03-2015

Privately-held Blueprint Medicines has entered a strategic collaboration with USA-based Alexion Pharmaceuticals…

Alexion PharmaceuticalsBlueprint MedicinesLicensingPharmaceuticalRare diseases

1 to 9 of 97892 results

COMPANY SPOTLIGHT

Menarini

Back to top